Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol. 2018 Feb 01; 4(2):196-202.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Double-Blind Method
Double-Blind Method
Drug Resistance, Neoplasm
Drug Resistance, Neoplasm
Female
Female
Humans
Humans
Indazoles
Indazoles
Middle Aged
Middle Aged
Neoplasm Metastasis
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Ovarian Neoplasms
Ovarian Neoplasms
Paclitaxel
Paclitaxel
Placebos
Placebos
Pyrimidines
Pyrimidines
Sulfonamides
Sulfonamides
Treatment Outcome
Treatment Outcome
authors with profiles
Debra L Richardson